期刊文献+

^(153)钐-乙二胺四甲基膦酸治疗多发性骨转移癌骨痛疗效观察 被引量:4

Clinical observation of multiple bone metastases with^(153) Sm-EDTMP
原文传递
导出
摘要 目的探讨 1 5 3钐 -乙二胺四甲基膦酸 (1 5 3Sm-EDTMP)核素治疗多发性骨转移癌的可行性。方法静脉注射1 5 3Sm-EDTMP 32例 ,每疗程剂量 0 .4~ 1.0 mci/kg(1m Ci=37MBq) ,肝静脉一次注入 ,其中 7例接受 2~ 3次治疗。结果骨痛完全缓解 5 3.1% (17/32 ) ,部分缓解 2 5 .0 % (8/32 ) ,轻度缓解 9.4% (3/32 ) ,无效 12 .5 % (4/32 ) ,总有效率为 78.1%。副作用为 WBC和 (或 ) PLT的 度、 度下降 ,占 15 .6 % (5 /32 ) ,6~ 8周内基本恢复至治疗前水平。结论 1 5 3  Sm-EDTMP治疗骨广泛转移癌 ,止痛效果确切 。 Objective To evaluate the feasibility of 153 Sm EDTMP for multiple bone metastasis.Methods 32 patients with multiple bone metastases were treated with 153 Sm EDTMP injected into the veins,0.4~1.0 mci/kg,of which 7 cases received therapy for 2~3 times.Results 53.1%(17/32)was relieved completely,25.0%(8/32)was relieved partially and 9.4%(3/32)was relieved slightly.No effects were found in 12.5%(4/32).The overall effective rate was 78.1%.Side effects that were the decreasing of WBC and PLT were found in 15.6%(5/32),which rose to the preoperative levels within 6~8 weeks.Conclusion Internal radiotherapy with 153 Sm EDTMP is safe and effective in the treatment of multiple bone metastases.
出处 《中国综合临床》 北大核心 2001年第5期370-371,共2页 Clinical Medicine of China
关键词 ^153钐 乙二胺四甲基膦酸 骨转移癌 骨痛 放射性核素 疗效 治疗 153 Sm EDTMP Bone metastases Internal radiotherapy
  • 相关文献

参考文献4

共引文献59

同被引文献40

  • 1邓候富,谭天秩,莫廷树,钟尚炎,匡安仁,胡赢州.骨转移癌治疗药物^(153)Sm-EDTMP对患者造血系统和重要器官的影响[J].华西医科大学学报,1995,26(2):155-159. 被引量:7
  • 2Han SH, De Klerk JM, Zonnenberg BA et al. ^186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone meta-tases[J]. Q J Nucl Med, 2001 ;45(1 ) :84-90. 被引量:1
  • 3Sciuto R, Tofani A, Festa A et al. Short and long-term effects of ^186 Re-l,l hydroxyethylidene diphosphonate in the treatment of painful bone metastases[ J]. J Nucl Med, 2000;41(4):647 -654. 被引量:1
  • 4Sciuto R, Fesa A, Pasqualoni R et al. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients[J]. Breast Cancer Res,2001 ;66(2) :101- 109. 被引量:1
  • 5Goddu SM, Bishayee A, Bouchet LG et al.Marrow toxicity of 33P-vesus 32Porthophosphate:implications for therapy of bone metastases[ J]. J Nucl Med,2000 ;41(5) :941 -951. 被引量:1
  • 6Arteaga de Murphy C, Ferro Flores G, Pedraza Lopez M. Labelling of Re-ABP with 188Re for bone pain palliation [ J]. Appl Radiat Isot, 2001 ;54 ( 3 ) :435 - 442. 被引量:1
  • 7Chakraborty S, Das T, Unni PR et al.177Lu labeled polyaminophosphonates as potential agents for bone pain palliation[ J ]. Nucl Med C ommun, 2002 ;23 ( 1 ) :67-74. 被引量:1
  • 8Giammarile F, Mognetti T, Blondet C et al. Bone pain palliation with 85Sr therapy[J].J Nucl Med,1999;40(4) :585 -590. 被引量:1
  • 9Bouchet LG, Bolch WE, Goddu SM et al.Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions[ J]. J Nucl Med,2000;41 (4) :682 -687. 被引量:1
  • 10Kalkner KM, Westlin JE, Strang P.89Strontium in the management of painful sceleal metastases [ J ]. Anticancer Res,2000;20(2B) :1109 - 1114. 被引量:1

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部